Short answer first, then the reasoning. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.

Dr.PeteFamMed said:

The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value.

Agreed, and reference ranges are laboratory-specific. Comparing your number to somebody else's range, or to a screenshot from another country, is how people convince themselves something is wrong.

sophie_paris said:

I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something…

This matches mine closely enough to be worth saying so. Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c becomes informative again, since it reflects about three months of glycaemia. After the first year, and once doses are stable, annual is reasonable unless something specific is being followed.

Adding the clinical framing, because it changes how the question reads.

Shot day Monday report relevant to baseline bloodwork:

Week 15. Currently on 0.5mg. Down 81 lbs from starting weight of 293 lbs.

This week's observations: Appetite very well controlled, no cravings.

Labs due next week — looking forward to seeing the metabolic panel. I'll post results in the Lab Results section when they come in.